Press-release for stocks related to pharm-country

| -100.0% | O: 0.25% H: 200.0% C: 200.0%
drug candidate research liver pre-clinical therapy cancer publication

NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
Published: 2022-11-28 (Crawled : 23:00) - biospace.com/
NAOV 4 | $0.7451 16

| -85.53% | O: 4.21% H: 138.89% C: 134.41%
fda clearance plus painshield

Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019
Published: 2021-08-17 (Crawled : 14:15) - biospace.com/
VRPX | $3.3 -10.33% -4.66% 5

| -21.43% | O: 57.38% H: 149.32% C: 132.22%
fda fda response response

Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date
Published: 2022-10-10 (Crawled : 15:00) - biospace.com/
APDN | $0.33 71K

Commercial Services

| -73.39% | O: -2.42% H: 96.69% C: 75.21%
dna order

gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
Published: 2022-01-12 (Crawled : 14:00) - biospace.com/
ECOR | $5.62 360

| 922.0% | O: 4.27% H: 70.91% C: 53.47%
treatment designation

RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
Published: 2022-12-05 (Crawled : 14:00) - biospace.com/
RSPI | $0.0009 0.0% 1.2M

| -75.0% | O: 0.0% H: 52.5% C: 52.5%
pharmaceuticals stroke collaboration neurological

GeneDx Announces Preliminary 2023 Financial Results
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
WGS | $10.39 7.4K

| 277.82% | O: 2.55% H: 39.05% C: 36.88%
financial results

DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Published: 2023-11-02 (Crawled : 11:00) - biospace.com/
AMWL | $0.5729 3.73% 35K

Technology Services

| -53.39% | O: -6.78% H: 22.73% C: 21.82%
SNY | News | $47.36 0.45% 120K

| 1.39% | O: 3.0% H: 0.0% C: 0.0%
DRIO | $1.32 280

| 30.69% | O: -26.73% H: 36.49% C: 36.49%
financial results

EvolveImmune Therapeutics to Present New Preclinical Data from Novel Costimulatory T Cell Engager Platform at Upcoming Scientific Conferences
Published: 2022-10-18 (Crawled : 12:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K

| -93.16% | O: -26.47% H: 36.0% C: 36.0%
preclinical therapeutics platform

BrainStorm Cell Therapeutics Submits Type A Meeting Request to U.S. Food and Drug Administration
Published: 2022-12-12 (Crawled : 13:00) - biospace.com/
BCLI A | $0.5401 1.8K

| -60.58% | O: 2.19% H: 34.28% C: 32.86%
drug meeting therapeutics food

Applied UV Installs Patented LumiCide Surface Disinfection Solution into NYC’s Mt. Sinai Medical Center Morningside
Published: 2022-06-14 (Crawled : 13:00) - biospace.com/
AUVI | $0.5911 10K

| -77.74% | O: 4.53% H: 46.93% C: 32.49%

RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RSPI | $0.0009 0.0% 1.2M

| -93.46% | O: -21.57% H: 32.5% C: 31.67%
commercialization

Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023
Published: 2023-03-14 (Crawled : 23:00) - biospace.com/
ELEV | $4.11 1.48% 4.4K

| 264.86% | O: -1.8% H: 34.86% C: 31.19%
research meeting association cancer

PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
Published: 2022-03-17 (Crawled : 18:00) - biospace.com/
LUCD | $0.7508 9K

| -76.56% | O: 2.5% H: 6.71% C: 4.88%
PAVM | $1.88 1.6K

| 49.21% | O: 1.59% H: 33.98% C: 28.91%
implant system success

Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
INTS | $3.86 -1.03% 690

| 59.15% | O: 0.39% H: 33.74% C: 28.05%
breast symposium presentation cancer therapeutics

New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy
Published: 2022-10-25 (Crawled : 15:20) - biospace.com/
PTPI | $0.671 3.2% 370K

| -82.94% | O: 9.68% H: 45.69% C: 26.56%
stendra

Sonnet BioTherapeutics Appoints Ms. Lori McNeill to the Board of Directors and Formalizes the Company's Business Advisory Committee
Published: 2022-09-26 (Crawled : 13:00) - biospace.com/
SONN | $1.7 0.3% 4.7K

| 5.59% | O: -6.21% H: 25.83% C: 23.84%

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients
Published: 2022-02-01 (Crawled : 15:00) - biospace.com/
SNPX | $4.43 1.61% 1.3K

| -44.1% | O: 5.13% H: 29.88% C: 23.05%
alzheimer disease alzheimer’s alzheimer's disease bryostatin alzheimer's

Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
Published: 2022-08-19 (Crawled : 14:00) - biospace.com/
APDN | $0.33 71K

Commercial Services

| -90.83% | O: -6.94% H: 38.21% C: 22.69%
monkeypox test dna diagnostic health state virus approval

Hoth Therapeutics to Present at the Diamond Equity Research Emerging Growth Invitational 2021 Virtual Conference
Published: 2021-02-17 (Crawled : 15:00) - biospace.com/
HOTH | $1.15 1.3K

| -53.82% | O: -0.4% H: 25.4% C: 22.58%
growth research

← Previous
1
2
3
4
5
6
7
8
9
…
102
103
Next →

Gainers vs Losers

81%

19%

Top 10 Gainers

MTTR | News M | $4.625 165.81% 5.5M

AGBA | $2.615 109.2% 14M

Finance

EDBL | News | $7.37 96.01% 650K

PALI | $7.64 54.97% 14M

OPRT | News | $3.19 41.78% 3M

Finance

PEGY | $0.0629 37.34% 110M

MLEC | $1.87 33.57% 1.6M

n/a

ATGL | $3.66 27.97% 150K

SMFL | $5.35 22.99% 11M

KULR | $0.5446 22.0% 6.8M